3D Tissue Models

View Profile


Membership in Professional Societies

Professional association Start year End year Title Comments
1. ACC/AHA/ACP Task Force on Cardiology 2014 Member
2. VA Merit Review 2014 Ad Hoc
3. American College of Cardiology 2014 Member, Expert Panel, Pennsylvania Chapter
4. Prelude. Eli Lilly & co 2014 2010 Member, DSMB
5. Heart Rhythm Society 2014 Fellow
6. Councils on Clinical Cardiology and Basic Science 2014 Fellow
7. American Heart Association 2014 Member, EKG Committee
8. American College of Chest Physicians 2014 Member, Council on Critical Care
9. American College of Clinical Pharmacology 2014 Fellow
10. College of Physicians of Philadelphia 2014 Fellow
11. Pennsylvania Cardiology Society 2014 Member
12. Cardiac Electrophysiology Society 2014 Member
13. Philadelphia Academy of Cardiology 2014 Member
14. The Physiological Society of Philadelphia 2014 Member
15. Dronedarone-Randazine for AF. 2011 (HARMONY) 2014 Chair, Steering Committee
16. Electrophysiology Self-Assessment Program (EPSAP) 2014 Member,Development Committee
17. AF Ablation Registry 2014 Planning Committee
18. American College of Physicians 2014 Fellow
19. Heart Rhythm Foundation 2014 Member, Board of Directors
20. American Heart Association 2014 Member, Southeastern Pennsylvania Affiliate
21. Board of Governors 2014 Member Executive Committee
22. Continuing Education Committee 2014 Member
23. CABANA 2014 Member, Steering Committee
24. American Society for Pharmacology and Experimental Therapeutics 2014 Member
25. American Federation for Clinical Research 2014 Member
26. Philadelphia Arrhythmia Group 2014 Co-founder
27. Society of Cardiovascular Disease in the Elderly 2014 Founding Member
28. European Cardiac Arrhythmia Society (ECAS) 2014 Founding Member
29. New Horizons Senior Center, Narberth, PA 2014 Member, Board of Directors
30. SPD 557-206 Shire Pharmaceuticals 2012 2014 Member, DMC
31. Reveal AF Medtronic 2011 2014 Member, Steering Committee
32. 3D Communications 2013 Member, CV Advisory Board
33. Dendreon 2012 2013 Member, Endpoint Committee
34. CADENCE, Otsuka 2011 2013 Co-Chair, Steering Committee
35. Pazopanib Trials, GSK 2011 2013 Member, IDMC
36. S/LI-606. Pfizer 2009 2013 Chair, Cardiac Endpoint Committee
37. Cardiac Endpoint Committee Roche 2009 2013 Member
38. Wyeth Pharmaceuticals 2008 2013 Chair, Cardiac Adjudication Committee
39. TACTIC-AF. St. Jude 2012 Member, Steering Committee
40. Inotuzumab, Pfizer 2012 Chair, Endpoint Committee
41. Academic Research Consortium 2011 2012 Member, Writing Committee
42. CARDIONET 2009 2012 Chair, Medical Advisory Board
43. ASSURE-AF. AstraZeneca 2008 2012 Co-chair, Steering Committee
44. Roflumilast Outcome Trials. Forest Labs 2011 Cardiac Endpoint Committee
45. Shield II (Azimilide for ICD Shock Prevention) 2011 Co-Chair, Steering Committee
46. American Society of Hypertension 2011 Member, Scientific Program Planning Committee
47. Oskira Project. Astra Zeneca and Quintiles 2011 Member, Endpoint Committee
48. American Heart Association 2009 2011 Member, Electrocardiography and Arrhythmias Committee
49. Astellas Pharmaceuticals 2009 2011 Member, Endpoint Adjudication Committee
50. American College of Cardiology 2008 2011 ACCEL Contributor, Credentialing and Membership Committee
51. ViiV Healthcare, HIV Product Development 2010 Member, Safety and Labeling Committee
52. ALPHEE (Dronedarone for ICD Shock Prevention) 2010 Chair, Steering Committee
53. St. Joseph’s University, Philadelphia 2010 Member, Board of Advisors
54. TIOSPIR B-I 2010 Member, Endpoint Adjudication Committee
55. STOP-AF Medical Advisory Board 2010 Member
56. AVANIR Pharmaceuticals 2009 2010 Member, Endpoint Committee
57. Johnson & Johnson Pharmaceuticals 2009 2010 Member, DSMB, Carisbamate 2003 protocol
58. DIA Annual QT Meeting 2005 2010 Member, Organizing Committee
59. Odiparcil for atrial fibrillation. GlaxoSmithKline, 2005 2010 Member, Steering Committee
60. Orbit AF Registry Steering Committee 2009 Member
61. American College of Cardiology 2009 Member, ECG and Arrhythmia Committee
62. SAFARI Registry, CSRC 2009 Co-chair, Steering Committee
63. Break Study, Synvista 2008 2009 Member, Data and Safety Monitoring Committee
64. RWJ-445380, RA Study C- 2006 2009 Member, Data and Safety Monitoring Committee
65. Drug Information Association Meeting Planning Committee 2003 2009 Member
66. CentroRelix, Aeferna Zentaris 2008 Member, Safety Monitoring Committee
67. BG 00012 Phase III Studies. Biogen Idec 2007 2008 Member, Data and Safety Monitoring Committee
68. RWJ-333369 Studies EPY-3001 and 3002. Johnson and Johnson Pharmaceuticals 2007 2008 Member, Data and Safety Monitoring Committee
69. YM-758 for AF Treatment. Astellas Pharmaceuticals, 2006 2008 Chairman, Data and Safety Monitoring Board
70. Alza Pharmaceuticals 2006 2008 fellow
71. RECORD AF Registry, Sanofi-Aventis 2006 2008 Member, Scientific Committee
72. AFFECTS Registry, Reliant Pharmaceuticals 2006 2008 Member, Steering Committee
73. Alzheimers Agent. Myriad Pharmaceuticals 2006 2008 Member, Data and Safety Monitoring Board
74. RHEOS, Baro-reflex modulation system, CVRx, Minneapolis 2006 2008 Member, Data and Safety Monitoring Committee
75. American College of Cardiology 2005 2008 Member, Clinical Electrophysiology Committee
76. Vascular Biology Working Group 2007 Member
77. Cardiac Safety Consortium. Duke University 2007 Member, Executive Committee and Scientific Oversight Committee
78. ICARIOS: Effect of SSR-149744C on ICD function. Sanofi-Synthelabo 2005 2007 Chairman, Steering Committee
79. ICLAPRIM, Arpida and Applied Clinical Intelligence 2005 2007 Member, Data and Safety Monitoring Committee
80. GAP-486 for the prevention of ischemia-related arrhythmias. Wyeth Pharmaceuticals 2005 2007 Chairman, Steering Committee
81. MAIA: SSR-149744C for Maintenance of sinus rhythm in patients with atrial fibrillation. Sanofi-Synthelabo 2005 2007 Chairman, Steering Committee
82. CORYFEE: Acute conversion of AF using SSR 149744C. Sanofi-Synthelabo 2005 2007 Chairman, Steering Committee
83. Odiparcil for non-valvular AF. GlaxoSmithKline 2004 2007 Member, Steering Committee
84. Tedisamil in AF. Solvay Pharmaceuticals 2002 2007 Member, Cardiac Safety Committee
85. Food and Drug Administration 1998 2007 Consultant, CardioRenal Division(Special Government Employee)
86. ACC Arrhythmia Course, Philadelphia, PA 2006 Chairman
87. American College of Cardiology 1998 2006 Contributor, ACCEL Program
88. Novartis 2005 Member, Cardiovascular & Cerebrovascular Safety Committee
89. Itopride, Axcan Pharmaceuticals, 2004 2005 Member, Data and Safety Monitoring Board
90. Heart Rhythm Society 2002 2005 Training and Fellowship Committee
91. ALT-711. Alteon 2000 2005 Member, Data and Safety Monitoring Board
92. US Pharmacopeial Convention 1996 2005 Expert Advisory Panel on Cardiovascular and Renal Drugs
93. ACC Arrhythmia Course, Philadelphia, PA 2004 Chairman
94. FTY 720, Novartis Pharmaceuticals 2002 2004 Member, Data and Safety Monitoring Board
95. Mosapride – Takeda Pharamceutical 2002 2004 Member, Data Safety Monitoring Board
96. Heart Rhythm Society 2001 2004 Advisory Council, Development Committee
97. Cooperative AF Trial, (Safe-T) 1999 2004 Member, Data and Safety Monitoring Board
98. Clinical Cardiac Electrophysiology, American Board of Internal Medicine 2003 Member, Self-Evaluation Process Committee
99. Pharmacia-Upjohn, 2000 2003 Member, Data and Safety Monitoring Board for summanirole
100. ACC Arrhythmia Course, Philadelphia, PA 2002 Chairman
101. Examining feasibility of establishing cardiology outpatient centers in Ireland 2002 Consultant, Global Health Practice
102. New Horizons Senior Center, Ardmore, PA 2002 Vice President, Board of Directors
103. NASPE Meetings 2001 2002 Abstract Committee, Co-Chair
104. St. Joseph’s University 2001 2002 Medical Alumni Committee
105. Heart Rhythm Society 2000 2002 Manpower Task Force, Publications Committee, Primary Care Subcommittee, Committee on Health Policy
106. Aqueous Amiodarone safety and efficacy in ventricular arrhythmia patients 2000 2002 Executive Committee
107. Heart Rhythm Society 1999 2002 Co-Chair Continuing Medical Educational Committee Co-Chair
108. INVEST 1999 2002 Chairman Endpoint Committee
109. Cardiovascular Medicine and Philadelphia Cardiology Board Review Course 1999 2002 Instructor, ACC National Board Review Course
110. Rhythmol-SR Atrial Fibrillation Trial (RAFT) 1998 2002 Member, Data and Safety Monitoring Board
111. American College of Cardiology Annual Scientific Session, March, 2001, and North American Society of Pacing and Electrophysiology, May, 2001 2001 Contributor, Medscape Review
112. Cardiology 1999 2001 Instructor, Philadelphia Board Review Course
113. Section on Antiarrhythmic Drugs 2000 Group Chair
114. Independence Blue Cross 2000 Medical Policy Consultant
115. ACC Arrhythmia Course, Philadelphia, PA 2000 Chairman
116. Rhythmol-SR Atrial Fibrillation Trial (RAFT). Knoll Pharmaceuticals 1997 2000 Member, Data and Safety Monitoring Board
117. Consensus Recommendations, American Journal of Cardiology 83 (2A), 1999 Member, Advisory Committee to Improve Outcomes Nationwide in Heart Failure
118. Losartan Diabetic Nephropathy Trial. Merck Research Laboratories 1996 1999 Member, Data and Safety Monitoring Board
119. Key Pharmaceuticals 1998 Member, National Potassium Council
120. U.S. Beta-Blocker Council 1998 Member
121. PDA-641 clinical program. Wyeth-Ayerst Research, 1996 1998 Member, Data and Safety Monitoring Board
122. Aetna-US Healthcare, Blue Bell, PA 1995 1998 Member, Quality Assurance Committee and Patient Management Advisory Committee
123. Up-to-Date in Clinical Medicine, Wellesley, MA 1997 Member, Writing Committee
124. ARVD Registry, Tuscon, AZ 1997 Member, Advisory Board
125. National Scientific Sessions of American College of Cardiology 1997 Member, Program Committee
126. Pioglitazone Trials. Takeda International 1996 1997 Member, Data and Safety Monitoring Board
127. Section on Antiarrhythmic Drugs 1996 Group Chair
128. IL-11 trials. Genetics Institute 1995 1996 Member, Data and Safety Monitoring Board
129. American Association for Advancement of Science 1995 1996 President
130. Clinical Research Award 1995 Ad Hoc Reviewer for Department of Veteran Affairs
131. Lankenau Hospital and Main Line Health System, 1995 Chairman, Cardiology Update
132. Carvedilol Congestive Heart Failure Trials 1993 1995 Member, Data and Safety Monitoring Board
133. ACC Electrophysiology 1994 Instructor, Board Review Course
134. Leonard Horowitz Lectureship, Philadelphia Arrhythmia Group, Philadelphia, PA 1993 Chairman
135. Food and Drug Administration 1989 1993 Consumer-Nominated Member, Cardiorenal Advisory Committee
136. ACC Electrophysiology 1992 Instructor, Board Review Course
137. Food and Drug Administration 1985 1989 Member, Cardiovascular Devices Panel
138. Food and Drug Administration 1984 1988 Consumer-Nominated Member, Cardiorenal Advisory Committee


About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.